(IN BRIEF) The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMAs) have jointly released a comprehensive Artificial…
(IN BRIEF) In a significant development for Africa's pharmaceutical sector, the African Pharmaceutical Technology Foundation and the Rwandan Government have…
(IN BRIEF) Roche (SIX: RO, ROG; OTCQX: RHHBY) has once again secured its position as one of the leading sustainable…
(IN BRIEF) The European Investment Bank (EIB) has signed a €20 million venture debt financing agreement with The Akkermansia Company,…
(IN BRIEF) Novadip, a Belgian biotech company, has secured €18 million in venture debt financing from the European Investment Bank…
(IN BRIEF) Novozymes and Chr. Hansen have unveiled their new collective name, 'Novonesis,' symbolizing a fresh beginning in the world…
(IN BRIEF) Roche, a global pharmaceutical company, has shared compelling data from its CD20xCD3 T-cell engaging bispecific antibody program during…
(IN BRIEF) In a significant development, GSK plc has received marketing authorization from the European Commission (EC) for Jemperli (dostarlimab)…
(IN BRIEF) In the Phase 3 IsKia trial presented at the American Society of Hematology (ASH) Annual Meeting, Sarclisa® (isatuximab)…
(IN BRIEF) Roche has announced promising results from the Phase III INAVO120 study, which evaluated inavolisib in combination with palbociclib…